681 related articles for article (PubMed ID: 20653331)
1. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers and risk of all-cause mortality in non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Repaci S; del Pinto M; Gentile G; Cavallini C; Reboldi G
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):109-18. PubMed ID: 20200201
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
[TBL] [Abstract][Full Text] [Related]
4. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
5. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
6. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?
McGory ML; Maggard MA; Ko CY
Surgery; 2005 Aug; 138(2):171-9. PubMed ID: 16153424
[TBL] [Abstract][Full Text] [Related]
8. Acute peri-operative beta blockade in intermediate-risk patients.
Biccard BM; Sear JW; Foëx P
Anaesthesia; 2006 Oct; 61(10):924-31. PubMed ID: 16978304
[TBL] [Abstract][Full Text] [Related]
9. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.
Blessberger H; Lewis SR; Pritchard MW; Fawcett LJ; Domanovits H; Schlager O; Wildner B; Kammler J; Steinwender C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013438. PubMed ID: 31556094
[TBL] [Abstract][Full Text] [Related]
10. Perioperative beta-blocker therapy and mortality after major noncardiac surgery.
Lindenauer PK; Pekow P; Wang K; Mamidi DK; Gutierrez B; Benjamin EM
N Engl J Med; 2005 Jul; 353(4):349-61. PubMed ID: 16049209
[TBL] [Abstract][Full Text] [Related]
11. Good news for β-blockers in perioperative medicine.
Angeli F; Reboldi G; Verdecchia P
Expert Opin Drug Saf; 2011 Jul; 10(4):491-8. PubMed ID: 21609193
[TBL] [Abstract][Full Text] [Related]
12. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
13. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD004476. PubMed ID: 29533470
[TBL] [Abstract][Full Text] [Related]
14. Perioperative issues: myocardial ischemia and protection--beta-blockade.
Maggio PM; Taheri PA
Surg Clin North Am; 2005 Dec; 85(6):1091-102, viii. PubMed ID: 16326195
[TBL] [Abstract][Full Text] [Related]
15. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
16. Clinical inquiries. Which patients undergoing noncardiac surgery benefit from perioperative beta-blockers?
Haynes J; Kelsberg G; Jamieson B; Lo V
J Fam Pract; 2008 Feb; 57(2):121-3. PubMed ID: 18248734
[No Abstract] [Full Text] [Related]
17. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
18. [Beta blockers reduce cardiac complications in patients undergoing surgery].
Hynynen M
Duodecim; 2000; 116(17):1805-7. PubMed ID: 12001633
[No Abstract] [Full Text] [Related]
19. [Perioperative beta-blockade for reduction of cardiovascular complications in non-cardiac surgery: advantages and disadvantages].
Koelemay MJ; Legemate DA
Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2603-5. PubMed ID: 19102434
[TBL] [Abstract][Full Text] [Related]
20. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
Saha SA; Molnar J; Arora RR
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
